Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:RMED

Ra Medical Systems (RMED) Stock Price, News & Analysis

Ra Medical Systems logo

About Ra Medical Systems Stock (NYSE:RMED)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.54
$1.10
52-Week Range
N/A
Volume
77,500 shs
Average Volume
197,480 shs
Market Capitalization
$3.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Stock News Headlines

“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Ra Medical Systems Inc (4RM.BE)
Ra Medical Systems Inc.
Catheter Precision Inc (VTAK)
See More Headlines

RMED Stock Analysis - Frequently Asked Questions

Ra Medical Systems, Inc (NYSE:RMED) posted its earnings results on Monday, November, 15th. The company reported ($57.50) earnings per share for the quarter, missing the consensus estimate of ($39.50) by $18.00. The business earned $0.01 million during the quarter, compared to analysts' expectations of $0.70 million.

Shares of Ra Medical Systems reverse split on the morning of Monday, October 3rd 2022.The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Ra Medical Systems (RMED) raised $50 million in an IPO on Thursday, September 27th 2018. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ra Medical Systems investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), Corbus Pharmaceuticals (CRBP), NIO (NIO), Vaxart (VXRT), iBio (IBIO) and Pfizer (PFE).

Company Calendar

Last Earnings
11/15/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:RMED
CIK
1716621
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($92.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.86 million
Net Margins
N/A
Pretax Margin
-97,518.88%
Return on Equity
-496.57%
Return on Assets
-344.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.86
Quick Ratio
2.85

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.29 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,370,000
Free Float
4,368,000
Market Cap
$3.19 million
Optionable
Not Optionable
Beta
-0.03
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:RMED) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners